| Title | The role of fentanyl in cancer-related pain. | | Author(s) | Prommer E | | Institution | Department of Hematology/Oncology/Palliative Care, Mayo Clinic Arizona, 5777 East Mayo Boulevard, Phoenix, AZ 85054, USA. prommer.eric@mayo.edu | | Source | J Palliat Med 2009 Oct; 12(10):947-54. | | Abstract | Fentanyl is a lipophilic, short-acting, synthetic opioid with a piperidine chemical structure. Fentanyl is an effective analgesic for cancer pain, and newer formulations such as the transmucosal and buccal forms have shown efficacy for the management of cancer-related breakthrough pain. This article reviews the pharmacodynamics, pharmacology, and clinical efficacy for this new option in treating moderate to severe pain. | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 19807240 |
|
